Navigation Links
UCB Announces Positive Results From Phase II Clinical Trial of Investigational Anti-Epilepsy Drug Brivaracetam
Date:12/3/2007

ATLANTA, Dec. 3 /PRNewswire/ -- UCB today announced data demonstrating that anti-epileptic drug (AED) brivaracetam, with the proposed trade name Rikelta(TM), administered as an adjunctive treatment in adults with refractory epilepsy with partial onset seizures, significantly reduced seizure frequency and had a side-effect profile comparable to placebo. The results of the two Phase IIb (Abstracts C.04 and 3.218), double-blind, randomized, parallel- group, placebo-controlled dose ranging studies were presented today as an oral platform presentation at the 61st annual meeting of the American Epilepsy Society.

"It is exciting to see the promising results that brivaracetam produced in this highly refractory population of epilepsy patients," said Jacqueline French, MD, lead study author and professor of neurology at New York University. "The development of novel anti-epilepsy drugs is vital to addressing the needs of treatment-resistant epilepsy patients. We look forward to seeing the results of our Phase III clinical research."

The two studies involved 365 patients, ages 16-65, with refractory partial onset seizures, which were uncontrolled despite treatment with one to two other AEDs. Patients in the first study (Abstract C.04) were randomized to receive 5 mg/day, 20 mg/day, 50 mg/day or placebo, administered twice-daily without titration over the seven week treatment period. The study found that brivaracetam reduced weekly seizure frequency over placebo by 9.8%, 14.9%, and 22.1% with doses of 5mg/day, 20 mg/day, and 50 mg/day, respectively, suggesting a dose response trend with brivaracetam 5 mg-50 mg/day.

An analysis of the study's secondary endpoints found that brivaracetam:

-- Reduced median seizure frequency from baseline by 29.9%, 42.6% and

53.1% for 5mg/day, 20mg/day and 50mg/day, respectively, compared with

21.7% for placebo.

-- Reduced weekly seizure frequency from baseline in 32.0%, 44.2% and


'/>"/>
SOURCE UCB, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
2. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
3. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
4. HEI, Inc. Announces Sale of RFID Division Assets
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
8. Brooke Franchise Corporation Announces Selected July Results
9. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
11. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... , ... September 03, 2015 , ... ... to healthcare providers, has been retained to lead a national chief executive ... top executive search firms in the healthcare industry, B. E. Smith has recently ...
(Date:9/3/2015)... ... , ... According to an Oncology Nurse Advisor article published on ... oropharyngeal cancer (oral cancer) to be successfully diagnosed and treated for relapses of the ... which have a high rate of success in treatment and elimination of the disease; ...
(Date:9/3/2015)... Indianapolis, IN (PRWEB) , ... September 03, 2015 ... ... Affordable Care Act (ACA) triggering cost increases for fully insured employer-sponsored health insurance ... among large employers (1,000+ employees), according to data released from the 2014 United ...
(Date:9/3/2015)... ... September 03, 2015 , ... ... is pleased to announce the additional of Carol Wysham, MD, to their esteemed ... members Diana Karczmarczyk, Donna Rice, David Warren, Matt Stella, Tricia Cedotal, Andrea Thomas, ...
(Date:9/3/2015)... (PRWEB) , ... September 03, ... ... provider of high-quality patient safety and efficacy endpoint data collection, cloud analytics ... European PRO and eCOA Congress in Lisbon, Portugal, September 22-24, 2015. The ...
Breaking Medicine News(10 mins):Health News:Melissa Memorial Hospital Retains B. E. Smith to Recruit New CEO 2Health News:Melissa Memorial Hospital Retains B. E. Smith to Recruit New CEO 3Health News:LA Periodontists Discuss Study on Post-Treatment Oral Rinses Used to Test Recurrence of Oral Cancers 2Health News:LA Periodontists Discuss Study on Post-Treatment Oral Rinses Used to Test Recurrence of Oral Cancers 3Health News:Self-Funded Pharmacy Plans Becoming More Popular Among Large Employers 2Health News:Self-Funded Pharmacy Plans Becoming More Popular Among Large Employers 3Health News:Self-Funded Pharmacy Plans Becoming More Popular Among Large Employers 4Health News:Carol H. Wysham, MD, Joins DiabetesSisters Board of Directors 2Health News:ERT Announces Final Agenda, Faculty for European PRO / eCOA Congress 2Health News:ERT Announces Final Agenda, Faculty for European PRO / eCOA Congress 3
... Start-up FundingMINNEAPOLIS, May 4 CoreSpine Technologies, a ... received 510(k) clearance to market from the U.S. ... Nucleus Removal System. "The clearance of the ... CoreSpine," said Christine Horton, Chief Executive Officer of ...
... wellness & HR summit for organizations in SE ... decision makers and HR professionals. Increase wellness, decrease ... productivity. TROY, Mich., May 4 Cambridge Employee ... host its fourth annual corporate Wellness & HR ...
... Group, a life science-focused strategic communications agency, announced today ... sciences agency client roster.Donna L. LaVoie, President & CEO ... working on the leading edge of the life sciences ... therapeutics for complex central nervous system disorders, Mithridion,s strategy ...
... Information from American Red CrossCHICAGO, May 4 As ... to the swine flu (H1N1 flu outbreak), millions of ... caregiver options. In response to this recent flu ... to Sittercity.com for the month of May. With ...
... members and 18 foreign associates from 15 countries elected recently to the ... ... CA (Vocus) May 4, 2009 -- Five UCSF faculty scientists ... countries elected recently to the National Academy of Sciences, the Academy has ...
... attention to urgency in preventing stroke and supporting 6 million stroke survivors ... ... year nearly 795,000 people will have a stroke, leaving a path of ... National Stroke Association , which is observing National Stroke Awareness Month ...
Cached Medicine News:Health News:CoreSpine Technologies(TM) Receives Clearance to Market Surgical Disc Preparation Device 2Health News:Cambridge Employee Benefits to Host Corporate Wellness & HR Summit 2Health News:LaVoie Group Appointed by Mithridion as PR Agency 2Health News:In-Home Caregivers Standing by Nationwide to Support Increased Need Due to Swine Flu 2Health News:Five UCSF Scientists Elected to National Academy of Sciences 2Health News:Five UCSF Scientists Elected to National Academy of Sciences 3Health News:Five UCSF Scientists Elected to National Academy of Sciences 4Health News:Five UCSF Scientists Elected to National Academy of Sciences 5Health News:Five UCSF Scientists Elected to National Academy of Sciences 6Health News:Five UCSF Scientists Elected to National Academy of Sciences 7Health News:Five UCSF Scientists Elected to National Academy of Sciences 8Health News:Four of Five Families Will Be Touched by Stroke in 2009 2
(Date:9/3/2015)... NEW YORK , Sept. 3, 2015 About ... in dryness of eyes due to deficient tear production ... This syndrome is of two types: aqueous tear deficient ... deficient dry eye, lacrimal glands do not produce enough ... eye. Meibomian glands secrete lipids to slow tear evaporation ...
(Date:9/3/2015)... 2015  Ascendis Pharma A/S (Nasdaq: ... that applies its innovative TransCon technology to ... plans to present at several upcoming investor ... in BostonDate: , Thursday, September 10, 2015 Time: ... Merrill Lynch Global Healthcare Conference in LondonDate: ...
(Date:9/3/2015)... , Sept. 3, 2015 Research and Markets ... "Global Medical Devices Packaging Market - By Packaging ... 2014 - 2020" report to their offering. ... is driven directly by its end use industry, i.e., ... the packaging of these devices so as to be ...
Breaking Medicine Technology:Global Dry Eye Syndrome Market 2015-2019 2Ascendis Pharma A/S to Present at Three Upcoming Investor Conferences 2Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 2Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 3Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 4Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 5Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 6Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 7Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 8
... Mass., July 21, 2011 Quanterix Corporation, ... science researchers and IVD labs single molecule ... that the analytical performance of AccuPSA™, a ... (PSA), demonstrated a robust 2-log improvement in ...
... 2011 China Nuvo Solar Energy, Inc. ... Definitive Agreement to acquire medical and surgical supply company ... Agreement, China Nuvo Solar ("Company") would acquire one hundred ... closing of the transaction is subject to customary closing ...
Cached Medicine Technology:Quanterix Digital Immunoassay for Prostate Specific Antigen Improves Analytical Performance 2China Nuvo Solar Announces Definitive Agreement Signed to Acquire Medical Products company SurgLine, Inc. 2
... The Avant® 4000 System with ... wired connections while ensuring reliable and ... all in a small package. The ... data to a small tabletop display, ...
The Dolphin Medical 2150 Pulse Oximeter consists of the Dolphin ONE OEM 701 Module technology, (1) extension cable, and (1) oximetry sensor to non-invasively calculate the functional saturation of ar...
Ergonomically designed, the Invacare Printing Pulse Oximeter provides fast, reliable spot-check information and documentation of SpO2 and pulse rate. It is ideal for all patients from neonate to adul...
The reliable and easy-to-use 3800 pulse oximeter is now more advanced - featuring TruTrak+ technology, the proprietary clinical motion algorithm from Datex+-Ohmeda....
Medicine Products: